TNFAIP3
TNFAIP3, also known as A20 or OTUD7C, is a zinc finger ubiquitin-editing enzyme with both ubiquitin ligase and deubiquitinase activities. It limits NF-kappa-B signalling downstream of cytokines such as TNF and IL-1 beta and of Toll-like receptors. Browse Assay Genie's current range of TNFAIP3 research reagents below, or read on for the biology behind the target.
TNFAIP3 is a ubiquitin-editing enzyme that combines ubiquitin ligase and deubiquitinase activities. It takes part in immune and inflammatory responses signalled by cytokines such as TNF and IL-1 beta, or by pathogens through Toll-like receptors, and it acts by terminating NF-kappa-B activity. It is an essential component of a ubiquitin-editing complex that also contains RNF11, ITCH and TAX1BP1, which ensures that inflammatory signalling stays transient.
Mechanistically, TNFAIP3 acts on several signalling nodes. Together with TAX1BP1 it promotes disassembly of E2-E3 ubiquitin ligase complexes in the IL-1R and TNFR-1 pathways, affecting the E3 ligases TRAF6, TRAF2 and BIRC2 and the E2 enzymes UBE2N and UBE2D3. After TNF stimulation it removes 'Lys-63'-linked polyubiquitin from RIPK1 and catalyses 'Lys-48'-linked chains, leading to RIPK1 proteasomal degradation. In T-cell receptor signalling it deubiquitinates MALT1, which separates the CBM and IKK complexes and prevents sustained IKK activation. It also deubiquitinates NEMO/IKBKG, with help from TNIP1, and can inhibit IKK through a non-catalytic, polyubiquitin-dependent mechanism. TRAF2 is targeted for lysosomal degradation. The protein also inhibits programmed cell death, has a role in the lymphoid system, and is required for LPS-induced production of pro-inflammatory cytokines and IFN beta in LPS-tolerised macrophages.
The TNFAIP3 gene was identified because its expression is rapidly induced by TNF, which gave rise to the name tumour necrosis factor, alpha-induced protein 3. The protein belongs to the peptidase C64 family and to the HGNC groups of OTU domain containing proteins, A20-type zinc fingers and atypical E3 ubiquitin ligases. Several transcript variants encode the same protein, and the mouse ortholog is Tnfaip3.
TNFAIP3 terminates NF-kappa-B activation, making it a central feedback regulator for studying how TNF, IL-1 beta and TLR signals are switched off.
Its dual ligase and deubiquitinase activities and action on Lys-11, Lys-48 and Lys-63 chains make it a model for ubiquitin editing.
TNFAIP3 shapes responses to LPS and bacterial peptidoglycans, including cytokine and IFN beta production in LPS-tolerised macrophages.
It deubiquitinates MALT1 during T-cell activation, supports lymphoid function and inhibits TNF-mediated programmed cell death.
TNFAIP3 is a ubiquitin-editing enzyme with ligase and deubiquitinase activities. It terminates NF-kappa-B signalling triggered by TNF, IL-1 beta and Toll-like receptors, acting on RIPK1, TRAF6, MALT1 and NEMO/IKBKG, and it inhibits programmed cell death.
Yes. A20 is an alias of TNFAIP3, and OTUD7C is another listed alias. The official name is TNF alpha induced protein 3, previously tumour necrosis factor, alpha-induced protein 3. Several transcript variants are reported, and they encode the same protein.
A mouse ortholog, Tnfaip3, is recorded in the data for this target. Reactivity depends on the individual reagent, so check the datasheet of any product for its validated reactivity.
Other TNF-induced proteins that are listed alongside TNFAIP3 at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P21580; product specifications from Assay Genie datasheets.